Company news
Gemina Laboratories Ltd news in 2022
Gemina Laboratories Ltd's news releases, calls and decks from 2022, newest first.
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 7, 2022
Gemina Labs Enters into Licence and Manufacturing Agreements
October 6, 2022
Gemina Labs Presents at the H.C. Wainwright Global Investment Conference
September 12, 2022
Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer
September 6, 2022
Gemina Labs Announces Closing Of Concurrent Private Placement
July 11, 2022
Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement
June 30, 2022
Gemina Announces Filing of Prospectus Supplement
June 24, 2022
Gemina Announces Proposed Financing Up to $5 Million
June 21, 2022
Gemina Labs Appoints Point-of-Care Diagnostic Executive Brian Firth as Advisor
June 8, 2022
Gemina Labs Announces CE Mark for its First Product - The Best in Class Legio-X COVID Rapid Antigen Test
May 17, 2022
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
May 5, 2022
Gemina Labs Nears Completion of Phase 2 Human Patient Testing for Initial Diagnostic Test
April 28, 2022
Gemina Labs Provides Technical Development Update for Initial Diagnostic Test and Reports Filing of New IP
March 31, 2022
Gemina Labs Establishes UK Subsidiary And Appoints David Browning As Head Of Productization
February 23, 2022
Gemina Labs Strategic Update: From Product to Platform, Gemina Provides a Technology Roadmap
February 15, 2022
Gemina Labs Announces Completion of Significant Development Step for its SARS-CoV-2 Rapid Test
February 3, 2022